Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Apyx Medical Inc

APYX
Current price
1.32 USD -0.12 USD (-8.33%)
Last closed 1.39 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 50 580 096 USD
Yield for 12 month -56.00 %
1Y
3Y
5Y
10Y
15Y
APYX
21.11.2021 - 28.11.2021

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Address: 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.63 USD

P/E ratio

Dividend Yield

Current Year

+52 349 000 USD

Last Year

+44 510 000 USD

Current Quarter

+14 662 000 USD

Last Quarter

+15 974 000 USD

Current Year

+14 122 000 USD

Last Year

+29 131 000 USD

Current Quarter

+4 062 000 USD

Last Quarter

+7 978 000 USD

Key Figures APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 009 000 USD
Operating Margin TTM -39.39 %
PE Ratio
Return On Assets TTM -18.8 %
PEG Ratio
Return On Equity TTM -58.26 %
Wall Street Target Price 3.63 USD
Revenue TTM 52 349 000 USD
Book Value 0.77 USD
Revenue Per Share TTM 1.51 USD
Dividend Share
Quarterly Revenue Growth YOY 16.3 %
Dividend Yield
Gross Profit TTM 29 131 000 USD
Earnings Share -0.54 USD
Diluted Eps TTM -0.54 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -35.75 %

Dividend Analytics APYX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation APYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.8413
Price Sales TTM 0.9662
Enterprise Value EBITDA -2.4317
Price Book MRQ 1.8424

Financials APYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators APYX

For 52 weeks

1.21 USD 7.97 USD
50 Day MA 1.92 USD
Shares Short Prior Month 1 566 509
200 Day MA 3.05 USD
Short Ratio 2.64
Shares Short 706 675
Short Percent 2.12 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

411.84 USD Microsoft Corporation -5.76 (-1.38%)
Detailed analytics

ETF funds


M

MDAXEX

208.40 CHF iShares MDAX UCITS ETF (DE) -12.16 (-5.06%)
Detailed analytics

Metals


Gold

2205.6 USD Gold +35.66 (+1.64%)
Detailed analytics